OrganiGram Reports 123% Increase In Sales For Second Quarter

Ontario-based medical marijuana company OrganiGram Holdings Inc. (OGRMF)  reported second-quarter results with record gross sales of C$3.2 million, a 123% increase over the same time period in 2017. The company also delivered net income in the second quarter of C$1.0 million over last year’s loss of C$5.7 million. The company also turned a corner on the earnings per share with the second-quarter delivery of diluted C$0.008 over last year’s loss per share of C$0.059.

“We are incredibly proud of what we have achieved in Q2 as we registered record sales and a profit for the quarter,” said Greg Engel the company’s CEO, “but we have also significantly bolstered our balance sheet and from an operational and sales and marketing perspective we are well positioned to take full advantage of not only the medical market but also the burgeoning adult recreational and international opportunities as well.”

Dried cannabis flower sales increased 68% in the quarter to 238 grams. But the real story was the 297% increase in sales in cannabis oil with 552 ml being sold versus last year’s 139ml.

While the company’s long-term debt rose C$3 million from year’s end to C$96 million, OrganiGram is sitting on C$178 million in cash.

Looking Ahead

The company said that the Phase 3 expansion is expected to be finished by June 1, 2018, and it will be able to start putting the first cannabis plants inside. This will bring the company’s run-rate capacity to 36,000 kg a year. In addition to that OrganiGram said that it will launch its adult-recreational brand strategy on or about May 15, 2018. The company also said it would be announcing one or more strategic international investments in the third quarter.

Stock Performance

OrganiGram stock was lately trading at $3.08 on the OTC Markets. This is lower than its 52-week high of $4.56 that was reached in the early part of 2018, but much improved from the year’s low of $1.49.

Debra Borchardt

Debra Borchardt is the CEO, Co-Founder, and Editor-In-Chief of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Masters degree in Business Journalism from New York University.

Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

@GreenMarketRpt – 2 days

New Report from ⁦@headset_io⁩ Says Medical Cannabis Consumers Spend More. New story from ⁦@julsaitch⁩

@GreenMarketRpt – 2 days

Yowza. Be careful when investing in crowdfunding deals. SEC files complaint against CEO and others for…

Back to Top